Non-operative Management in Locally Advanced Rectal Cancer Patients with Clinical Complete Response After Chemoradiotherapy Followed by Consolidation Chemotherapy: A Single Center Experience
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Purpose This study aims to analyze the long-term clinical outcomes of non-operative management (NOM) in locally advanced mid/distal rectal cancer patients who had a complete clinical response (cCR) following neoadjuvant chemoradiotherapy (nCRT) and consolidation chemotherapy. Methods Locally advanced mid/distal rectal cancer patients with stage II/III amenable for surgery who received nCRT followed by consolidation chemotherapy were enrolled into this study. Patients with an incomplete response following nCRT at any stage underwent surgery and patients with a significant clinical response were treated with FOLFOX (5-fluorouracil and oxaliplatin) or CapeOx (capecitabine and oxaliplatin). Patients with a cCR after nCRT followed by consolidation chemotherapy were managed with NOM. Results A total of 173 patients treated between January 2014 and March 2025 were enrolled in this observational cohort study. All of these patients were treated with total neoadjuvant treatment and received especially nCRT and consolidation chemotherapy. 83 patients with cCR were followed up with NOM. The rate of local regrowth was 19.3% (n = 16) with all patients having an endoluminal growing pattern confined to the first two years. Distant metastases were diagnosed in 7 (8.4%) out of 83 patients. Disease-free survival and overall survival were 78.3% and 95.2%. Conclusion The long-term clinical outcomes of NOM were promising in terms of pelvic tumor control and overall survival in strictly selected patients who had cCR after nCRT followed by consolidation chemotherapy.
Source: Research Square
Institution: Istanbul University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7236756452
